| Description | Vonlerolizumab(MOXR 0916) is a humanized IgG agonistic OX40-specific monoclonal antibody with potential antitumor activity for the study of tumors and immune diseases. |
| Synonyms | Pogalizumab, RG 7888, MOXR 0916 |
| molecular weight | N/A |
| CAS | 1638935-72-4 |
| Storage | store at low temperature | store at -20°C |
| References | 1. Marin-Acevedo JA, et al. Next generation of immune checkpoint therapy in cancer: new developments and challenges. J Hematol Oncol. 2018 Mar 15;11(1):39. |